Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus
- PMID: 7129630
- PMCID: PMC347655
- DOI: 10.1128/iai.37.3.1112-1118.1982
Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus
Abstract
Four isolates of Staphylococcus aureus from patients with endocarditis and bacteremia were capable of secreting high-molecular-weight soluble peptidoglycans when grown in a minimal cell wall medium containing penicillin G. Vancomycin was not able to substitute for penicillin G in triggering this secretion. Secretion reflected de novo synthesis of soluble peptidoglycan and was strongly dependent on time of incubation (30 to 60 min), and number of bacteria (2 X 10(8) to 5 X 10(8) colony-forming units per ml), but not on penicillin G concentration (10 to 250 micrograms/ml). The incorporation of alanine into the peptidoglycans secreted in vitro by these isolates incubated in the presence of penicillin G under optimal conditions was variable. The least incorporation of alanine into peptidoglycan occurred with an isolate from a patient treated with nafcillin who had no detectable antipeptidoglycan titer.
Similar articles
-
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.Chemotherapy. 1984;30(5):328-30. doi: 10.1159/000238288. Chemotherapy. 1984. PMID: 6092007
-
Neither an enhancement of autolytic wall degradation nor an inhibition of the incorporation of cell wall material are pre-requisites for penicillin-induced bacteriolysis in staphylococci.Arch Microbiol. 1985 May;141(4):309-14. doi: 10.1007/BF00428842. Arch Microbiol. 1985. PMID: 4015304
-
A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates.Antimicrob Agents Chemother. 2001 Jan;45(1):280-7. doi: 10.1128/AAC.45.1.280-287.2001. Antimicrob Agents Chemother. 2001. PMID: 11120978 Free PMC article.
-
The role of vancomycin in the treatment paradigm.Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S51-7. doi: 10.1086/491714. Clin Infect Dis. 2006. PMID: 16323121 Review.
-
Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.Infection. 2015 Dec;43(6):751-4. doi: 10.1007/s15010-015-0763-0. Epub 2015 Mar 25. Infection. 2015. PMID: 25805524 Free PMC article. Review.
Cited by
-
Detection of soluble peptidoglycan in urine after penicillin administration.Infect Immun. 1984 Jan;43(1):139-42. doi: 10.1128/iai.43.1.139-142.1984. Infect Immun. 1984. PMID: 6690400 Free PMC article.
-
Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.Infect Immun. 1995 Aug;63(8):3158-65. doi: 10.1128/iai.63.8.3158-3165.1995. Infect Immun. 1995. PMID: 7542639 Free PMC article.
-
Isolation and characterization of soluble peptidoglycan from several strains of Streptococcus faecium.J Bacteriol. 1984 Aug;159(2):511-9. doi: 10.1128/jb.159.2.511-519.1984. J Bacteriol. 1984. PMID: 6746571 Free PMC article.
-
Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities.Antimicrob Agents Chemother. 1998 Dec;42(12):3073-8. doi: 10.1128/AAC.42.12.3073. Antimicrob Agents Chemother. 1998. PMID: 9835493 Free PMC article.
-
Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments.Clin Diagn Lab Immunol. 2001 May;8(3):647-51. doi: 10.1128/CDLI.8.3.647-651.2001. Clin Diagn Lab Immunol. 2001. PMID: 11329475 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
